Biomarin Pharmaceutical (BMRN) Share-based Compensation Growth (5y) (2014 - 2026)
Biomarin Pharmaceutical (BMRN) Share-based Compensation Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.57% |
| Dec 31, 2025 | -20.43% |
| Sep 30, 2025 | 52.25% |
| Jun 30, 2025 | 42.88% |
| Mar 31, 2025 | 6.10% |
| Dec 31, 2024 | 15.57% |
| Sep 30, 2024 | -41.30% |
| Jun 30, 2024 | 28.09% |
| Mar 31, 2024 | 6.38% |
| Dec 31, 2023 | 17.65% |
| Sep 30, 2023 | -3.06% |
| Jun 30, 2023 | -15.70% |
| Mar 31, 2023 | 7.03% |
| Dec 31, 2022 | -37.06% |
| Sep 30, 2022 | 87.83% |
| Jun 30, 2022 | -15.84% |
| Mar 31, 2022 | 9.29% |
| Dec 31, 2021 | 43.33% |
| Sep 30, 2021 | 10.23% |
| Jun 30, 2021 | -39.40% |